Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
2567543 | Pulmonary Pharmacology & Therapeutics | 2008 | 7 Pages |
Abstract
High doses of BDP/formoterol did not significantly reduce serum potassium, while formoterol alone did to a greater extent. The BDP/formoterol combination was well tolerated, and exhibited a safety profile generally similar to formoterol alone when administered in high doses to stable asthmatic patients.
Related Topics
Health Sciences
Medicine and Dentistry
Pulmonary and Respiratory Medicine
Authors
Dave Singh, Annalisa Piccinno, Zoe Borrill, Gianluigi Poli, Daniela Acerbi, Luc Meuleners, Ashley Woodcock,